See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2019_Surgery_Partners_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.46686567164179105, 'aggregate_val': 1607400000, 'exp_sum': 3015000000, 'exp_to_value': {'LaborExpense': 550000000, 'CostOfGoodsAndServicesSold': 1407600000, 'GeneralAndAdministrativeExpense': 88600000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 617200000, 'DepreciationDepletionAndAmortization': 76500000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 275100000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.44181279195987727, 'aggregate_val': 1720079000, 'exp_sum': 3081545000, 'exp_to_value': {'LaborExpense': 534740000, 'CostOfGoodsAndServicesSold': 1361431000, 'GeneralAndAdministrativeExpense': 93558000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 594557000, 'DepreciationDepletionAndAmortization': 67440000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 429819000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 3,437,139,000 |
| 1 | AssetsNonCurrent | 36,850,000 |
| 2 | AssetsCurrent | 588,322,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 613,956,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 349,299,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 534,740,000 |
| 9 | CostOfGoodsAndServicesSold | 1,361,431,000 |
| 10 | GeneralAndAdministrativeExpense | 93,558,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 594,557,000 |
| 13 | DepreciationDepletionAndAmortization | 67,440,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -931,647,000 |
| 17 | remainder_Revenues | 1,771,456,000 |
| 18 | remainder_NetIncome | -147,003,000 |
| 19 | remainder_ComprehensiveNetIncome | -132,526,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,676,267,000 |
| 1 | Liabilities | 349,299,000 |
| 2 | Expenses | 1,720,079,000 |
| 3 | Revenues | 1,771,456,000 |
| 4 | StockholdersEquity | 4,326,968,000 |
| 5 | NetIncome | -95,626,000 |
| 6 | ComprehensiveNetIncome | -228,152,000 |
| 7 | BaseVar | 4,398,315,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.41 |
| 9 | EconomicCapitalRatio | 2.67 |